Liver cirrhosis
Conditions
Interventions
healthy control:coagulation tests
patients admitted with liver cirrhosis:coagulation tests
patients guided by conventional coagulation tests:plasma transfusion guided by conventional coagulation tests
patients guided by TEG:plasma transfusion guided by TEG
Sponsors
Department of Blood Transfusion, Daping Hospital, Research Institute of Surgery, Third Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 79 years old; 2. patients admitted to Digestive Department with a diagnosis of liver cirrhosis; 3. Patients who are willing to participate in the study with informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who are unable to communicate due to a history of stroke, epilepsy, or primary brain cancer patients, cancer patients with brain metastases; 2. cirrhosis patients with hepatocellular carcinoma; 3. patients with liver dysfunction or liver failure; 4. patients who have taken medicines that may affect the coagulation function(like heparin, coumarin anticoagulants andthrombin inhibitors); 5. patients who have serious organic disease in heart, lung or kidney; 6. pregnant or lactating women; 7. patients who are involved in another clinical research; 8. patients who refuse to participate in the research; 9. patients who took part in other clinical drug test in 3 month before being enrolled in our study; 10. other situations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TEG characteristics in different Child-Pugh class cirrhosis patients;evaluation standard of TEG by different Child-Pugh class; | — |
Countries
China
Contacts
Public ContactWen Aiqing
Outcome results
None listed